Various new muscle relaxants are available: atracurium, rocuronium and
vecuronium all have an intermediate duration of action, whereas doxac
urium and pipecuronium are long-acting and mivacurium is a short-actin
g nondepolarizing muscle relaxant. The duration of action of atracuriu
m and mivacurium is determined by their degradation, which makes them
unique among the nondepolarizing muscle relaxants in this respect. The
time of onset is shortest with rocuronium, while vecuronium is probab
ly the muscle relaxant with the fewest undesirable side-effects. Tn cl
inical practice, muscle relaxants of short and intermediate duration o
f action should be preferred, since such agents carry the least risk o
f residual neuromuscular block postoperatively. Because recovery from
them is slow, long-acting agents should preferentially be used only wh
en postoperative mechanical ventilation is intended. The use of a peri
pheral nerve stimulator is the only reliable guide to appropriate admi
nistration of muscle relaxants.